267 related articles for article (PubMed ID: 17339183)
21. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
22. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies.
Niehues T; Kapaun P; Harms DO; Burdach S; Kramm C; Körholz D; Janka-Schaub G; Göbel U
Leukemia; 1999 Apr; 13(4):614-7. PubMed ID: 10214870
[TBL] [Abstract][Full Text] [Related]
23. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
24. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in china.
Tong H; Wang Q; Lu C; Liu Z; Hu Y
J Pediatr Hematol Oncol; 2011 Aug; 33(6):437-41. PubMed ID: 21792039
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
Amirghofran Z; Daneshbod Y; Gholijani N
Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
[TBL] [Abstract][Full Text] [Related]
28. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
Amirghofran Z; Daneshbod Y; Gholijani N; Esmaeilbeig M
Arch Iran Med; 2011 May; 14(3):170-4. PubMed ID: 21529104
[TBL] [Abstract][Full Text] [Related]
29. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
30. Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
Chevallier P; Delaunay J; Turlure P; Pigneux A; Hunault M; Garand R; Guillaume T; Avet-Loiseau H; Dmytruk N; Girault S; Milpied N; Ifrah N; Mohty M; Harousseau JL
J Clin Oncol; 2008 Nov; 26(32):5192-7. PubMed ID: 18854573
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia.
de Nully Brown P; Jurlander J; Pedersen-Bjergaard J; Victor MA; Geisler CH
Leuk Res; 1997 Oct; 21(10):985-95. PubMed ID: 9403009
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
33. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
Stock W; Johnson JL; Stone RM; Kolitz JE; Powell BL; Wetzler M; Westervelt P; Marcucci G; DeAngelo DJ; Vardiman JW; McDonnell D; Mrózek K; Bloomfield CD; Larson RA
Cancer; 2013 Jan; 119(1):90-8. PubMed ID: 22744771
[TBL] [Abstract][Full Text] [Related]
34. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
35. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
[TBL] [Abstract][Full Text] [Related]
36. [Immunophenotypes in 207 pediatric patients with ALL and theirs correlation with cytogenetics and clinical features].
Tong HX; Wang QS; Lu CW; Wang H; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):696-701. PubMed ID: 21729553
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival.
Dalal BI; Al Mugairi A; Pi S; Lee SY; Khare NS; Pal J; Bryant A; Vakil AP; Lau S; Abou Mourad YR
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):239-44. PubMed ID: 24411984
[TBL] [Abstract][Full Text] [Related]
38. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.
Vitale A; Guarini A; Ariola C; Mancini M; Mecucci C; Cuneo A; Pane F; Saglio G; Cimino G; Tafuri A; Meloni G; Fabbiano F; Recchia A; Kropp MG; Krampera M; Cascavilla N; Ferrara F; Romano A; Mazza P; Fozza C; Paoloni F; Vignetti M; Foà R
Blood; 2006 Jan; 107(2):473-9. PubMed ID: 16179376
[TBL] [Abstract][Full Text] [Related]
39. Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation.
van't Veer MB; van Putten WL; Verdonck LF; Ossenkoppele GJ; Löwenberg B; Kluin-Nelemans JC; Wijermans PW; Schouten HC; Sizoo W; Dekker AW
Ann Hematol; 1993 Jun; 66(6):277-82. PubMed ID: 7686403
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
